GeneDx Holdings Corp.
WGS
$86.48
$0.610.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.20% | 32.25% | 37.90% | 49.55% | 50.38% |
| Total Other Revenue | 115.18% | 214.32% | 230.12% | 112.48% | -18.45% |
| Total Revenue | 25.42% | 34.09% | 39.97% | 50.50% | 48.70% |
| Cost of Revenue | 17.01% | 17.52% | 16.54% | 12.80% | 9.90% |
| Gross Profit | 29.53% | 42.90% | 53.34% | 76.17% | 79.69% |
| SG&A Expenses | 55.63% | 43.28% | 38.36% | 27.89% | 14.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.05% | 38.27% | 33.66% | 23.67% | 11.37% |
| Operating Income | -1,196.73% | -136.24% | 49.60% | 119.95% | 107.08% |
| Income Before Tax | -7,020.25% | -101.81% | 59.84% | 102.98% | 101.30% |
| Income Tax Expenses | -52.31% | 79.57% | 66.18% | 158.08% | 115.20% |
| Earnings from Continuing Operations | -7,664.51% | -101.70% | 59.80% | 102.49% | 101.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7,664.51% | -101.70% | 59.80% | 102.49% | 101.20% |
| EBIT | -1,196.73% | -136.24% | 49.60% | 119.95% | 107.08% |
| EBITDA | -220.78% | -206.30% | 700.76% | 239.39% | 158.40% |
| EPS Basic | -10,438.18% | -84.38% | 63.35% | 102.42% | 100.78% |
| Normalized Basic EPS | -532.88% | -21.94% | 63.24% | 122.35% | 113.05% |
| EPS Diluted | -21,588.76% | -85.13% | 62.51% | 101.84% | 100.37% |
| Normalized Diluted EPS | -545.84% | -23.44% | 62.29% | 121.84% | 112.67% |
| Average Basic Shares Outstanding | 4.74% | 5.58% | 6.52% | 7.21% | 6.92% |
| Average Diluted Shares Outstanding | 3.65% | 6.65% | 7.61% | 8.32% | 8.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |